MENU
ITOS
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
iTeos Therapeutics (ITOS) Ownership - Who owns iTeos Therapeutics?
Profile
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
383.48M
P/E Ratio
N/A
Total Cash
571.26M
Projected Growth
N/A
Total Debt
5.52M
Revenue
35M
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash/Share
15.64
Total Debt/Equity
N/A
Revenue/Share
0.95 USD as % of share price
Fundamentals
ITOS
Capitalization
383M
P/E Ratio
N/A
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash
571M
Total Cash/Share
15.64
Total Debt
5.52M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.95%
Revenue
35M
ROE
N/A
Book Value
664M
P/B Ratio
0.56
Cash Flow
N/A
Earnings
-2.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
37K
Current Ratio
18.08
Current Revenue Per Employee
222929.94
Dividends Per Share - Security
N/A
EBITDA
-136.64M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-14.86
Shares Held By Institutions
1.56B
Shares Outstanding - Current
36.5M
Total Liabilities
88M
Total Volume MTD
N/A
Value
-1
Gain YTD
-17.900
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development of biopharmaceuticals therapeutic products and services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com